State-matched organoid models to fight pancreatic cancer
- PMID: 35370114
- DOI: 10.1016/j.trecan.2022.03.003
State-matched organoid models to fight pancreatic cancer
Abstract
As one of the deadliest cancers, pancreatic ductal adenocarcinoma (PDAC) requires sophisticated model systems to dissect disease onset, progression, and therapy resistance, as well as to personalize therapy. In recent years, patient- and pluripotent stem cell-derived organoids have become state-of-the-art systems to refine existing therapeutic strategies and deepen our knowledge of disease pathophysiology.
Keywords: organoids; pancreatic cancer; personalized medicine; stem cells.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no conflicts of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials